临床和实验医学杂志
臨床和實驗醫學雜誌
림상화실험의학잡지
JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
2015年
10期
836-839
,共4页
周建华%朱勇冬%郑文川%陈燕%林琬%林麒%田贤先
週建華%硃勇鼕%鄭文川%陳燕%林琬%林麒%田賢先
주건화%주용동%정문천%진연%림완%림기%전현선
偏头痛%美托洛尔%氟西汀5-羟色胺
偏頭痛%美託洛爾%氟西汀5-羥色胺
편두통%미탁락이%불서정5-간색알
Migraine%Metoprolol%Fluoxetine%5 - hydroxytryptamine
目的探讨美托洛尔联合氟西汀预防偏头痛的疗效及可能机制。方法将112例偏头痛患者按照随机数字表法随机分为观察组和对照组,每组各56例。观察组给予琥珀酸美托洛尔联合氟西汀治疗;对照组给予琥珀酸美托洛尔治疗。比较两组受试者治疗前和治疗后头痛发作次数、头痛发作程度、头痛发作天数、颅内动脉血流情况。记录两组治疗前、治疗后2周、治疗后4周、治疗后6周血清5羟色胺(5- HT)水平。结果两组治疗后头痛发作次数、头痛发作程度、头痛发作时间均较治疗前有明显改善( P <0.05),且观察组改善幅度优于对照组,差异有统计学意义( P <0.01);两组治疗后大脑中动脉(MCA)、前动脉(ACA)、后动脉(PCA)、椎动脉(VA)、基底动脉(VA)血流情况均较治疗前改善( P <0.05),且观察组改善幅度优于对照组,差异有统计学意义( P <0.01);两组治疗前血清5- HT 水平比较差异无统计学意义( P >0.05),观察组治疗后2周、4周、6周血清5- HT 水平较治疗前明显提高( P <0.01),且提高幅度大于同期对照组,差异有统计学意义( P <0.01);观察组未出现严重不良反应。观察组偏头痛复发率低于对照组,差异有统计学意义( P <0.05)。结论琥珀酸美托洛尔联合氟西汀预防性治疗偏头痛,比起单药应用,起效更快,疗效更明显,复发率更低;可有效改善患者偏头痛症状和颅内血流状况,疗效确切,其主要机制可能与提升患者体内5- HT 浓度有关。
目的探討美託洛爾聯閤氟西汀預防偏頭痛的療效及可能機製。方法將112例偏頭痛患者按照隨機數字錶法隨機分為觀察組和對照組,每組各56例。觀察組給予琥珀痠美託洛爾聯閤氟西汀治療;對照組給予琥珀痠美託洛爾治療。比較兩組受試者治療前和治療後頭痛髮作次數、頭痛髮作程度、頭痛髮作天數、顱內動脈血流情況。記錄兩組治療前、治療後2週、治療後4週、治療後6週血清5羥色胺(5- HT)水平。結果兩組治療後頭痛髮作次數、頭痛髮作程度、頭痛髮作時間均較治療前有明顯改善( P <0.05),且觀察組改善幅度優于對照組,差異有統計學意義( P <0.01);兩組治療後大腦中動脈(MCA)、前動脈(ACA)、後動脈(PCA)、椎動脈(VA)、基底動脈(VA)血流情況均較治療前改善( P <0.05),且觀察組改善幅度優于對照組,差異有統計學意義( P <0.01);兩組治療前血清5- HT 水平比較差異無統計學意義( P >0.05),觀察組治療後2週、4週、6週血清5- HT 水平較治療前明顯提高( P <0.01),且提高幅度大于同期對照組,差異有統計學意義( P <0.01);觀察組未齣現嚴重不良反應。觀察組偏頭痛複髮率低于對照組,差異有統計學意義( P <0.05)。結論琥珀痠美託洛爾聯閤氟西汀預防性治療偏頭痛,比起單藥應用,起效更快,療效更明顯,複髮率更低;可有效改善患者偏頭痛癥狀和顱內血流狀況,療效確切,其主要機製可能與提升患者體內5- HT 濃度有關。
목적탐토미탁락이연합불서정예방편두통적료효급가능궤제。방법장112례편두통환자안조수궤수자표법수궤분위관찰조화대조조,매조각56례。관찰조급여호박산미탁락이연합불서정치료;대조조급여호박산미탁락이치료。비교량조수시자치료전화치료후두통발작차수、두통발작정도、두통발작천수、로내동맥혈류정황。기록량조치료전、치료후2주、치료후4주、치료후6주혈청5간색알(5- HT)수평。결과량조치료후두통발작차수、두통발작정도、두통발작시간균교치료전유명현개선( P <0.05),차관찰조개선폭도우우대조조,차이유통계학의의( P <0.01);량조치료후대뇌중동맥(MCA)、전동맥(ACA)、후동맥(PCA)、추동맥(VA)、기저동맥(VA)혈류정황균교치료전개선( P <0.05),차관찰조개선폭도우우대조조,차이유통계학의의( P <0.01);량조치료전혈청5- HT 수평비교차이무통계학의의( P >0.05),관찰조치료후2주、4주、6주혈청5- HT 수평교치료전명현제고( P <0.01),차제고폭도대우동기대조조,차이유통계학의의( P <0.01);관찰조미출현엄중불량반응。관찰조편두통복발솔저우대조조,차이유통계학의의( P <0.05)。결론호박산미탁락이연합불서정예방성치료편두통,비기단약응용,기효경쾌,료효경명현,복발솔경저;가유효개선환자편두통증상화로내혈류상황,료효학절,기주요궤제가능여제승환자체내5- HT 농도유관。
Objective To study effect of metoprolol combined with fluoxetine treating migraine and its possible mechanism. Methods During the period of 2011 January to 2014 December,112 cases of migraine patients were selected as the research object. 112 patients were ran-domly divided into observation group and control group,56 cases in each group. The observation group included 56 patients,who were given Meto-prolol Tablets combined fluoxetine treatment. The patients of control group of 56 patients were treated with Metoprolol. The statistics of the two subjects,episodes of headache degree,headache days,intracranial arterial blood flow headache before and after the treatment were made. The re-cords of serum level of 5 - HT of the two groups before treatment,2 weeks after the treatment,4 weeks after the treatment,6 weeks after the treat-ment were made. Results Headache attack frequency,headache degree,headache time improved in two groups after treatment than before treat-ment( P < 0. 05). The observation group improved better than the control group,and there were significant differences( P < 0. 01). The two group after treatment,MCA,ACA,PCA,VA,VA were improved compared with before treatment( P < 0. 05),and the observation group im-proved better than the control group,and there were significant differences( P < 0. 01). The serum 5 - HT level was not statistically different be-tween the two groups before treatment( P > 0. 05),the observation group after treatment for 2 weeks,4 weeks,6 weeks,the levels of serum 5 -HT than before treatment significantly increased( P < 0. 01),which was greater than the same period in the control group,and there were signifi-cant differences( P < 0. 01). There was no serious adverse reaction in the observation group. The migraine recurrence rate of the observation group′s was lower than the control group,and there were significant differences( P < 0. 05). Conclusion Metoprolol combined with fluoxetine treating migraine,compared with the single drug application,has faster onset,and its curative effect is more obvious,and the recurrence rate is lower. It can effectively improve the patients′ migraine symptoms and intracranial blood flow condition,and its curative effect is accurate,and its main mechanism is to enhance 5 - HT concentration in patients.